Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04602611 · ClinicalTrials.gov registry record · NA

Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
228
Enrollment target

NCT04602611: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT04602611 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04602611, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
228 participants
Enrollment target

Study Summary

The purpose of this study is to learn about the impact of the Oncology Nurse Navigation program on the frequency of Emergency Department, urgent care visits and inpatient hospital admissions; and overall survival rate at 6 months. The investigators aim to understand if prompt and effective coordination of care provided by Oncology Nurse Navigation (ONN) service will reduce the number of avoidable, unplanned ED visits and hospitalizations, as well as adding measurable value to cancer care, and improve patient overall survival.

Primary Outcome

The annualized count of acute care visits, where acute care visits included all unplanned inpatient admissions, emergency room encounters, and/or urgent care visits, was calculated for each subject as the total number of acute care visits normalized to an annual basis.

Interventions

  • OTHER Oncology Nurse Navigation

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2020-11-03
Est. Completion 2023-08-10
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT04602611 record still lists

NCT04602611 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which Oncology Nurse Navigation is the first listed.

NCT04602611 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04602611 about?

NCT04602611 is a clinical study titled "Impact Of Nurse Navigation Program on Outcomes in Patients With GI Cancers". The purpose of this study is to learn about the impact of the Oncology Nurse Navigation program on the frequency of Emergency Department, urgent care visits and inpatient hospital admissions; and overall survival rate at 6 months. The investigators aim to understand if prompt and effective coordinat...

What is the current status of trial NCT04602611?

This trial is currently completed. It is a NA study. The enrollment target is 228 participants. The study started on 2020-11-03. Estimated completion is 2023-08-10.

What interventions are being tested in trial NCT04602611?

The interventions under investigation include: Oncology Nurse Navigation (OTHER).

Who is sponsoring clinical trial NCT04602611?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04602611's enrollment target sits among peer trials

228 468th of 2000 higher than 1,530 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05107908 · 228 participants · NA

    Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

  • NCT05547698 · 228 participants · NA

    A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

  • NCT05630963 · 228 participants

    Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression

  • NCT06073665 · 228 participants · Phase 4

    Dosing of LT4 in Older Individuals

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04602611, the US trial registry maintained by the National Library of Medicine. NCT04602611 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.